Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free CMMB Stock Alerts $0.82 -0.04 (-4.65%) (As of 05/21/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Chemomab Therapeutics Stock Price Performance5 Day Performance-5.75%1 Month Performance+20.59%3 Month Performance+21.30%6 Month Performance+64.33%Year-To-Date Performance+60.78%1 Year Performance-54.32% Receive CMMB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThis Could be Your “Big Money” AI MomentBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. CMMB Stock Chart for Tuesday, May, 21, 2024 CMMB Chart by TradingView Chemomab Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2024$0.86$0.82-4.65%$0.88$0.8269,972 shs$9.06 million05/20/2024$0.84$0.86+2.26%$0.86$0.8314,995 shs$9.50 million05/17/2024$0.87$0.84-3.33%$0.88$0.8353,810 shs$9.29 million05/16/2024$0.87$0.87-0.23%$0.88$0.8242,980 shs$9.61 million05/15/2024$0.88$0.87-0.91%$0.88$0.8255,086 shs$9.64 million05/14/2024$0.81$0.88+8.11%$0.88$0.81100,414 shs$9.72 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/13/2024$0.84$0.81-2.98%$0.88$0.8147,004 shs$9.00 million05/10/2024$0.81$0.84+3.58%$0.85$0.7666,540 shs$9.27 million05/09/2024$0.73$0.81+11.72%$0.85$0.69124,839 shs$8.95 million05/08/2024$0.89$0.73-18.42%$0.90$0.60423,449 shs$8.01 million05/07/2024$0.85$0.89+4.21%$0.97$0.76401,034 shs$9.82 million05/06/2024$0.74$0.85+15.24%$0.91$0.801.26 million shs$9.42 million05/03/2024$0.74$0.74+0.65%$0.74$0.7013,292 shs$8.18 million05/02/2024$0.73$0.74+1.35%$0.74$0.6712,160 shs$8.12 million05/01/2024$0.70$0.73+3.63%$0.73$0.6660,165 shs$8.02 million04/30/2024$0.68$0.70+2.94%$0.72$0.6613,802 shs$7.74 million04/29/2024$0.64$0.68+6.27%$0.69$0.6219,959 shs$7.51 million04/26/2024$0.66$0.64-2.90%$0.65$0.6223,560 shs$7.07 million04/25/2024$0.67$0.66-1.64%$0.68$0.6311,539 shs$7.28 million04/24/2024$0.67$0.67$0.68$0.653,373 shs$7.40 million04/23/2024$0.66$0.67+1.53%$0.68$0.647,157 shs$7.40 million04/22/2024$0.68$0.66-2.96%$0.67$0.629,520 shs$7.29 million04/19/2024$0.70$0.68-2.86%$0.74$0.6615,392 shs$7.51 million04/18/2024$0.59$0.70+18.64%$0.70$0.6229,623 shs$7.74 million04/17/2024$0.66$0.59-10.70%$0.69$0.5847,936 shs$6.52 million04/16/2024$0.73$0.66-9.49%$0.74$0.6637,664 shs$7.30 million04/15/2024$0.77$0.73-5.17%$0.77$0.7250,209 shs$8.07 million04/12/2024$0.76$0.77+1.29%$0.79$0.7511,602 shs$8.51 million04/11/2024$0.79$0.76-3.80%$0.79$0.7637,690 shs$8.40 million04/10/2024$0.79$0.79$0.80$0.7813,545 shs$8.73 million04/09/2024$0.79$0.79-0.08%$0.80$0.7815,638 shs$8.73 million04/08/2024$0.80$0.79-1.18%$0.80$0.7872,926 shs$8.74 million04/05/2024$0.79$0.80+1.28%$0.80$0.7735,680 shs$8.84 million04/04/2024$0.81$0.79-2.12%$0.80$0.7643,417 shs$8.73 million04/03/2024$0.77$0.81+5.49%$0.81$0.7555,417 shs$8.92 million04/02/2024$0.77$0.77$0.77$0.7416,400 shs$8.45 million04/01/2024$0.78$0.77-1.80%$0.79$0.7633,958 shs$8.45 million03/29/2024$0.78$0.78$0.78$0.7528,961 shs$8.61 million03/28/2024$0.77$0.78+1.17%$0.78$0.7528,961 shs$8.61 million03/27/2024$0.75$0.77+2.80%$0.78$0.7048,121 shs$8.51 millionEverybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.03/26/2024$0.73$0.75+3.03%$0.77$0.7044,367 shs$8.28 million03/25/2024$0.77$0.73-5.60%$0.80$0.70294,863 shs$8.03 million03/22/2024$0.79$0.77-2.40%$0.79$0.7625,006 shs$8.51 million03/21/2024$0.79$0.79-0.01%$0.82$0.7634,183 shs$8.72 million03/20/2024$0.77$0.79+2.45%$0.81$0.7579,554 shs$8.72 million03/19/2024$0.80$0.77-3.19%$0.80$0.76120,379 shs$8.51 million03/18/2024$0.80$0.80-0.48%$0.81$0.7728,062 shs$8.79 million03/15/2024$0.83$0.80-3.58%$0.83$0.7812,293 shs$8.83 million03/14/2024$0.82$0.83+0.61%$0.83$0.7761,375 shs$9.16 million03/13/2024$0.86$0.82-4.19%$0.88$0.81132,529 shs$9.11 million03/12/2024$0.82$0.86+4.26%$0.88$0.81202,130 shs$9.50 million03/11/2024$0.78$0.82+6.44%$0.83$0.77211,271 shs$9.12 million03/08/2024$0.80$0.78-3.13%$0.80$0.7597,778 shs$8.56 million03/07/2024$0.71$0.80+12.63%$0.82$0.71299,369 shs$8.84 million03/06/2024$0.65$0.71+9.78%$0.73$0.64310,081 shs$7.85 million03/05/2024$0.66$0.65-1.30%$0.65$0.6234,173 shs$7.15 million03/04/2024$0.66$0.66-0.68%$0.67$0.6241,599 shs$7.24 million03/01/2024$0.69$0.66-3.65%$0.67$0.6361,773 shs$7.29 million02/29/2024$0.68$0.69+1.18%$0.69$0.6537,317 shs$7.57 million02/28/2024$0.68$0.68-0.10%$0.68$0.6437,481 shs$7.48 million02/27/2024$0.67$0.68+1.15%$0.68$0.64113,924 shs$7.49 million02/26/2024$0.73$0.67-7.59%$0.72$0.65105,558 shs$7.40 million02/23/2024$0.75$0.73-3.33%$0.74$0.68105,212 shs$8.01 million02/22/2024$0.68$0.75+10.95%$0.75$0.62458,089 shs$8.29 million02/21/2024$0.67$0.68+0.90%$0.70$0.58557,465 shs$7.47 million02/20/2024$0.63$0.67+6.37%$0.71$0.558.94 million shs$7.40 million Related Companies: MTEM Stock Chart ATHE Stock Chart NCNA Stock Chart GRTX Stock Chart UPC Stock Chart ADXN Stock Chart AEZS Stock Chart GHSI Stock Chart MBRX Stock Chart MIRA Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchNew Options need New Trading StrategiesNetpicksThis military-backed stock “owns” AI marketPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.